Accelerate Diagnostics
AXDX
#10564
Rank
A$1.29 M
Marketcap
A$0.05121
Share price
0.00%
Change (1 day)
-97.90%
Change (1 year)

Operating Margin for Accelerate Diagnostics (AXDX)

Operating Margin as of December 2025 (TTM): -428.37%

According to Accelerate Diagnostics's latest financial reports and stock price the company's current Operating Margin is -428.37%. At the end of 2024 the company had an Operating Margin of -428.37%.

Operating Margin history for Accelerate Diagnostics from 2001 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-428.37%-14.99%
2023-503.92%2.7%
2022-490.67%-25.56%
2021-659.12%-5.9%
2020-700.43%-22.86%
2019-907.99%-41.57%
2018-1,554.06%2.17%
2017-1,521.07%-94.34%
2016-26,872.76%-13.18%
2015-30,951.02%22.07%
2014-25,354.92%-20.36%
2013-31,837.50%1314.73%
2012-2,250.42%6561.45%
2011-33.78%-224%
201027.24%-150.94%
2009-53.48%-84.87%
2008-353.37%-66.37%
2007-1,050.75%-26.25%
2006-1,424.83%242.18%
2005-416.40%-70.93%
2004-1,432.23%-57.44%
2003-3,365.17%2961.86%
2002-109.91%-49.57%
2001-217.95%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Thermo Fisher Scientific
TMO
16.22%-103.79%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
14.13%-103.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
8.81%-102.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
-32.94%-92.31%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
-97.64%-77.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bruker
BRKR
2.16%-100.50%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.